Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Netflix loses challenge in suit on poaching Fox execs, Bloomberg says » 06:18
12/03/21
12/03
06:18
12/03/21
06:18
NFLX

Netflix

$615.82 /

-1.93 (-0.31%)

, FOXA

Fox Corp.

$35.35 /

+0.95 (+2.76%)

, FOX

Fox Corp.

$32.85 /

+0.61 (+1.89%)

Netflix (NFLX) lost its…

Netflix (NFLX) lost its appeal to a court decision that the company stop poaching fixed-term staff from Twentieth Century Fox (FOXA, FOX), Bloomberg's Maeve Allsup reports, citing a California appellate court. Fox sued Netflix in 2016, claiming the streaming service attracted certain Fox executives to depart the company and a state trial court ordered an injunction. Reference Link

ShowHide Related Items >><<
NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

NFLX Netflix
$615.82 /

-1.93 (-0.31%)

11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/15/21 KeyBanc
Netflix price target raised to $725 from $690 at KeyBanc
11/15/21 JPMorgan
Netflix entering 'strongest content quarter ever,' says JPMorgan
FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

11/04/21 Deutsche Bank
Fox Corp. price target raised to $47 from $43 at Deutsche Bank
09/30/21
Fly Intel: Top five analyst upgrades
09/30/21 Rosenblatt
Rosenblatt upgrades Fox on expected favorable FanDuel outcome
09/30/21 Rosenblatt
Fox Corp. upgraded to Buy from Neutral at Rosenblatt
FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

08/05/21 Guggenheim
Guggenheim upgrades Fox Corp. to Buy, maintains $41 price target
05/06/21 RBC Capital
Fox Corp. price target raised to $42 from $36 at RBC Capital
05/06/21 UBS
Fox Corp price target raised to $39 from $30 at UBS
04/27/21 Morgan Stanley
Fox Corp. price target raised to $45 from $36 at Morgan Stanley
NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

  • 16
    Nov
NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

FOX Fox Corp.
$32.85 /

+0.61 (+1.89%)

NFLX Netflix
$615.82 /

-1.93 (-0.31%)

FOXA Fox Corp.
$35.35 /

+0.95 (+2.76%)

Thursday
Periodicals
United Airlines to shift operations staff to Chicago suburb, Bloomberg says » 15:20
12/02/21
12/02
15:20
12/02/21
15:20
UAL

United Airlines

$41.57 /

+2.46 (+6.29%)

United Airlines intends…

United Airlines intends to shift its network operations center that coordinates its flights globally to a Chicago suburb in 2022, reducing headcount at the company's global headquarters at Willis Tower in Chicago, Bloomberg's Julie Johnsson reports. The plan was announced internally and will affect roughly 900 staff, including managers and technical support workers, the author notes.

ShowHide Related Items >><<
UAL United Airlines
$41.57 /

+2.46 (+6.29%)

UAL United Airlines
$41.57 /

+2.46 (+6.29%)

10/21/21 Cowen
United Airlines price target raised to $78 from $72 at Cowen
08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
UAL United Airlines
$41.57 /

+2.46 (+6.29%)

UAL United Airlines
$41.57 /

+2.46 (+6.29%)

UAL United Airlines
$41.57 /

+2.46 (+6.29%)

UAL United Airlines
$41.57 /

+2.46 (+6.29%)

Wednesday
On The Fly
#SocialStocks: Facebook forced to sell Giphy by CMA » 15:57
12/01/21
12/01
15:57
12/01/21
15:57
FB

Facebook; also tag MVRS

$313.70 /

-10.725 (-3.31%)

, MVRS

Meta

/

+

, TWTR

Twitter

$43.35 /

-0.6 (-1.37%)

, AMZN

Amazon.com

$3,469.73 /

-39.2 (-1.12%)

, DTEGY

Deutsche Telekom

$17.74 /

-0.49 (-2.69%)

, VOD

Vodafone

$14.67 /

-0.005 (-0.03%)

, NFLX

Netflix

$619.92 /

-22.35 (-3.48%)

, GOOG

Alphabet

$2,862.00 /

+11.95 (+0.42%)

, GOOGL

Alphabet Class A

$2,848.81 /

+8.87 (+0.31%)

, TEF

Telefonica

$4.27 /

-0.071675 (-1.65%)

, TLSNY

Telia

$7.65 /

-0.09 (-1.16%)

, ORAN

Orange

$10.68 /

-0.045 (-0.42%)

, KKPNY

KPN

$2.95 /

-0.015 (-0.51%)

, BTGOF

BT Group

$2.10 /

-0.08 (-3.67%)

, TKAGY

Telekom Austria

$17.53 /

+ (+0.00%)

, BGAOY

Proximus

$3.57 /

-0.04 (-1.11%)

, TELNY

Telenor

$14.67 /

-0.53 (-3.49%)

, SCMWY

Swisscom

$55.46 /

-0.1 (-0.18%)

, ZM

Zoom Video

$198.48 /

-13.1 (-6.19%)

Welcome to…

ShowHide Related Items >><<
ZM Zoom Video
$198.48 /

-13.1 (-6.19%)

VOD Vodafone
$14.67 /

-0.005 (-0.03%)

TWTR Twitter
$43.35 /

-0.6 (-1.37%)

TEF Telefonica
$4.27 /

-0.071675 (-1.65%)

ORAN Orange
$10.68 /

-0.045 (-0.42%)

NFLX Netflix
$619.92 /

-22.35 (-3.48%)

GOOGL Alphabet Class A
$2,848.81 /

+8.87 (+0.31%)

GOOG Alphabet
$2,862.00 /

+11.95 (+0.42%)

FB Facebook; also tag MVRS
$313.70 /

-10.725 (-3.31%)

DTEGY Deutsche Telekom
$17.74 /

-0.49 (-2.69%)

AMZN Amazon.com
$3,469.73 /

-39.2 (-1.12%)

FB Facebook; also tag MVRS
$313.70 /

-10.725 (-3.31%)

12/02/21 UBS
Meta assumed with a Buy at UBS
11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
MVRS Meta
/

+

11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
TWTR Twitter
$43.35 /

-0.6 (-1.37%)

12/02/21 UBS
Twitter assumed with a Neutral at UBS
12/02/21 Piper Sandler
Twitter price target lowered to $54 from $70 at Piper Sandler
12/01/21 Citi
Twitter price target lowered to $47 from $60 at Citi
11/30/21 Jefferies
Twitter leadership changes 'step in right direction,' says Jefferies
AMZN Amazon.com
$3,469.73 /

-39.2 (-1.12%)

12/02/21 UBS
Amazon.com assumed with a Buy at UBS
11/24/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
11/22/21 Guggenheim
Amazon.com assumed with a Buy at Guggenheim
11/19/21 RBC Capital
Williams-Sonoma price target raised to $219 from $199 at RBC Capital
DTEGY Deutsche Telekom
$17.74 /

-0.49 (-2.69%)

12/01/21 JPMorgan
Deutsche Telekom price target lowered to EUR 26.50 from EUR 28 at JPMorgan
11/15/21 UBS
Deutsche Telekom price target raised to EUR 24.50 from EUR 24.20 at UBS
10/18/21 Deutsche Bank
Deutsche Telekom named short-term investment idea at Deutsche Bank
10/14/21 JPMorgan
Deutsche Telekom price target lowered to EUR 28 from EUR 29 at JPMorgan
VOD Vodafone
$14.67 /

-0.005 (-0.03%)

11/18/21 UBS
Vodafone price target raised to 188 GBp from 187 GBp at UBS
10/28/21 JPMorgan
Vodafone price target lowered to 160 GBp from 165 GBp at JPMorgan
10/18/21 Deutsche Bank
Vodafone named short-term investment idea at Deutsche Bank
09/07/21 Bernstein
Vodafone initiated with an Outperform at Bernstein
NFLX Netflix
$619.92 /

-22.35 (-3.48%)

11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/15/21 KeyBanc
Netflix price target raised to $725 from $690 at KeyBanc
11/15/21 JPMorgan
Netflix entering 'strongest content quarter ever,' says JPMorgan
GOOG Alphabet
$2,862.00 /

+11.95 (+0.42%)

11/02/21 Morgan Stanley
Alphabet price target raised to $3,200 from $3,000 at Morgan Stanley
10/27/21 Wedbush
Alphabet Class A price target raised to $3,530 from $3,424 at Wedbush
10/27/21 Jefferies
Alphabet price target raised to $3,500 from $3,325 at Jefferies
GOOGL Alphabet Class A
$2,848.81 /

+8.87 (+0.31%)

12/02/21 UBS
Alphabet assumed with a Buy at UBS
10/27/21 BMO Capital
Alphabet target raised to $3,200 from $3,000 at BMO Capital
TEF Telefonica
$4.27 /

-0.071675 (-1.65%)

11/23/21 Berenberg
Telefonica downgraded to Hold from Buy at Berenberg
10/25/21 Morgan Stanley
Telefonica price target lowered to EUR 4.60 from EUR 4.70 at Morgan Stanley
10/15/21 Barclays
Telefonica downgraded to Underweight from Equal Weight at Barclays
09/21/21 JPMorgan
Telefonica price target raised to EUR 3.70 from EUR 3.30 at JPMorgan
TLSNY Telia
$7.65 /

-0.09 (-1.16%)

11/08/21 HSBC
Telia upgraded to Hold from Reduce at HSBC
10/22/21 Barclays
Telia price target lowered to SEK 45 from SEK 46 at Barclays
09/14/21 Citi
Telia upgraded to Neutral from Sell at Citi
09/13/21 Barclays
Telia downgraded to Equal Weight from Overweight at Barclays
ORAN Orange
$10.68 /

-0.045 (-0.42%)

10/27/21 Barclays
Orange price target lowered to EUR 9.40 from EUR 9.50 at Barclays
10/26/21 JPMorgan
Orange price target raised to EUR 27 from EUR 25.50 at JPMorgan
10/18/21 Deutsche Bank
Orange price target lowered to EUR 15.50 from EUR 16 at Deutsche Bank
09/07/21 Bernstein
Orange initiated with a Market Perform at Bernstein
KKPNY KPN
$2.95 /

-0.015 (-0.51%)

10/18/21 Deutsche Bank
KPN named short-term investment idea at Deutsche Bank
10/15/21 Barclays
KPN upgraded to Overweight from Equal Weight at Barclays
09/30/21 Morgan Stanley
KPN price target raised to EUR 3 from EUR 2.80 at Morgan Stanley
08/25/21 Morgan Stanley
KPN price target raised to EUR 2.80 from EUR 2.70 at Morgan Stanley
BTGOF BT Group
$2.10 /

-0.08 (-3.67%)

11/05/21 JPMorgan
BT Group price target raised to 255 GBp from 235 GBp at JPMorgan
10/18/21 Deutsche Bank
BT Group price target lowered to 125 GBp from 140 GBp at Deutsche Bank
10/13/21 HSBC
BT Group downgraded to Reduce from Hold at HSBC
09/07/21 Bernstein
BT Group initiated with a Market Perform at Bernstein
TKAGY Telekom Austria
$17.53 /

+ (+0.00%)

10/01/21 JPMorgan
Telekom Austria price target raised to EUR 9.50 from EUR 9.40 at JPMorgan
07/27/21 JPMorgan
Telekom Austria price target raised to EUR 9.40 from EUR 8.10 at JPMorgan
07/16/21 Barclays
Telekom Austria price target raised to EUR 7.20 from EUR 7.10 at Barclays
06/25/21 Barclays
Telekom Austria price target raised to EUR 7.10 from EUR 7 at Barclays
BGAOY Proximus
$3.57 /

-0.04 (-1.11%)

12/01/21 JPMorgan
Proximus price target raised to EUR 19 from EUR 18.30 at JPMorgan
12/01/21 JPMorgan
Proximus upgraded to Neutral from Underweight at JPMorgan
11/04/21 JPMorgan
Proximus price target lowered to EUR 18.30 from EUR 19 at JPMorgan
10/06/21 UBS
Proximus price target lowered to EUR 17.80 from EUR 18 at UBS
TELNY Telenor
$14.67 /

-0.53 (-3.49%)

11/04/21 JPMorgan
Telenor price target lowered to NOK 140 from NOK 152 at JPMorgan
10/29/21 Barclays
Telenor price target lowered to NOK 135 from NOK 150 at Barclays
10/19/21 JPMorgan
Telenor price target lowered to NOK 152 from NOK 156 at JPMorgan
10/04/21 UBS
Telenor price target lowered to NOK 163 from NOK 165 at UBS
SCMWY Swisscom
$55.46 /

-0.1 (-0.18%)

11/08/21 HSBC
Swisscom downgraded to Hold from Buy at HSBC
11/05/21 JPMorgan
Swisscom price target lowered to CHF 620 from CHF 624 at JPMorgan
11/01/21 Barclays
Swisscom price target lowered to CHF 470 from CHF 475 at Barclays
11/01/21 UBS
Swisscom price target lowered to CHF 490 from CHF 510 at UBS
ZM Zoom Video
$198.48 /

-13.1 (-6.19%)

11/30/21 Daiwa
Zoom Video upgraded to Underperform from Sell at Daiwa
11/23/21
Fly Intel: Top five analyst downgrades
11/23/21 BofA
Zoom Video downgraded to Neutral from Buy at BofA
11/23/21 Wells Fargo
Zoom Video price target lowered to $245 from $275 at Wells Fargo
ZM Zoom Video
$198.48 /

-13.1 (-6.19%)

TWTR Twitter
$43.35 /

-0.6 (-1.37%)

NFLX Netflix
$619.92 /

-22.35 (-3.48%)

GOOG Alphabet
$2,862.00 /

+11.95 (+0.42%)

FB Facebook; also tag MVRS
$313.70 /

-10.725 (-3.31%)

AMZN Amazon.com
$3,469.73 /

-39.2 (-1.12%)

  • 13
    Jan
ZM Zoom Video
$198.48 /

-13.1 (-6.19%)

VOD Vodafone
$14.67 /

-0.005 (-0.03%)

TWTR Twitter
$43.35 /

-0.6 (-1.37%)

TEF Telefonica
$4.27 /

-0.071675 (-1.65%)

NFLX Netflix
$619.92 /

-22.35 (-3.48%)

MVRS Meta
/

+

GOOG Alphabet
$2,862.00 /

+11.95 (+0.42%)

FB Facebook; also tag MVRS
$313.70 /

-10.725 (-3.31%)

DTEGY Deutsche Telekom
$17.74 /

-0.49 (-2.69%)

AMZN Amazon.com
$3,469.73 /

-39.2 (-1.12%)

ZM Zoom Video
$198.48 /

-13.1 (-6.19%)

VOD Vodafone
$14.67 /

-0.005 (-0.03%)

TWTR Twitter
$43.35 /

-0.6 (-1.37%)

TEF Telefonica
$4.27 /

-0.071675 (-1.65%)

NFLX Netflix
$619.92 /

-22.35 (-3.48%)

GOOG Alphabet
$2,862.00 /

+11.95 (+0.42%)

FB Facebook; also tag MVRS
$313.70 /

-10.725 (-3.31%)

DTEGY Deutsche Telekom
$17.74 /

-0.49 (-2.69%)

AMZN Amazon.com
$3,469.73 /

-39.2 (-1.12%)

ZM Zoom Video
$198.48 /

-13.1 (-6.19%)

VOD Vodafone
$14.67 /

-0.005 (-0.03%)

TWTR Twitter
$43.35 /

-0.6 (-1.37%)

NFLX Netflix
$619.92 /

-22.35 (-3.48%)

GOOGL Alphabet Class A
$2,848.81 /

+8.87 (+0.31%)

FB Facebook; also tag MVRS
$313.70 /

-10.725 (-3.31%)

AMZN Amazon.com
$3,469.73 /

-39.2 (-1.12%)

VOD Vodafone
$14.67 /

-0.005 (-0.03%)

Hot Stocks
United Airlines to be first to fly aircraft using 100% sustainable fuel » 09:03
12/01/21
12/01
09:03
12/01/21
09:03
UAL

United Airlines

$42.25 /

-0.295 (-0.69%)

United will operate an…

United will operate an unprecedented flight that will serve as a turning point in the industry's effort to combat climate change: for the first time in aviation history, a commercial carrier will fly an aircraft full of passengers using 100% sustainable aviation fuel. Also, United announced the second round of corporate participants in the airline's Eco-Skies Alliance program to collectively contribute towards the purchase of SAF. The demonstration flight - which will depart today with more than 100 passengers from Chicago's O'Hare International Airport and land at Washington, D.C.'s Reagan National Airport - will be on a new United 737 MAX 8 and use 500 gallons of SAF in one engine and the same amount of conventional jet fuel in the other engine to further prove there are no operational differences between the two and to set the stage for more scalable uses of SAF by all airlines in the future. Currently, airlines are only permitted to use a maximum of 50% SAF on board. The SAF used on today's flight is drop-in ready and compatible with existing aircraft fleets.

ShowHide Related Items >><<
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

10/21/21 Cowen
United Airlines price target raised to $78 from $72 at Cowen
08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

Hot Stocks
Viatris announces appeals court upholds invalidation of Biogen Tecfidera patent » 07:04
12/01/21
12/01
07:04
12/01/21
07:04
VTRS

Viatris

$12.32 /

-0.19 (-1.52%)

, BIIB

Biogen

$235.67 /

-0.68 (-0.29%)

Viatris (VTRS) announced…

Viatris (VTRS) announced that the United States Court of Appeals for the Federal Circuit affirmed the June 2020 decision by the U.S. District Court for the Northern District of West Virginia invalidating Biogen's (BIIB) Tecfidera patent, U.S. Patent No. 8,399,514, for lack of written description. The company launched the first therapeutically equivalent substitutable generic to Tecfidera in August 2020.

ShowHide Related Items >><<
VTRS Viatris
$12.32 /

-0.19 (-1.52%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

VTRS Viatris
$12.32 /

-0.19 (-1.52%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
BIIB Biogen
$235.67 /

-0.68 (-0.29%)

11/30/21 Wedbush
Wedbush keeps Neutral rating on Biogen after court denies appeal in patent case
11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
VTRS Viatris
$12.32 /

-0.19 (-1.52%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

VTRS Viatris
$12.32 /

-0.19 (-1.52%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

Hot Stocks
Sage Therapeutics and Biogen report positive data on depression disorder drug » 06:34
12/01/21
12/01
06:34
12/01/21
06:34
SAGE

Sage Therapeutics

$38.85 /

+0.24 (+0.62%)

, BIIB

Biogen

$235.67 /

-0.68 (-0.29%)

Sage Therapeutics (SAGE)…

Sage Therapeutics (SAGE) and Biogen (BIIB) announced 12-month data for the cohort of patients who received zuranolone 50 mg once nightly for 14-days as their initial dose in the ongoing Phase 3 open-label SHORELINE Study and had the opportunity to be followed for 12-months. The SHORELINE Study, part of the LANDSCAPE clinical program, was designed to naturalistically follow adult patients with major depressive disorder - MDD - and evaluate the safety and tolerability of zuranolone as well as the need for repeat dosing for up to one year. For the primary endpoint of safety and tolerability, the data analyzed to date show zuranolone was generally well-tolerated, with no new safety findings or trends identified in the long-term safety data available regardless of the number of courses of zuranolone a patient received. Zuranolone has demonstrated improvements in depressive symptoms and a well-tolerated safety profile throughout the LANDSCAPE clinical program. Secondary endpoints included the percentage of patients who received repeat dosing with zuranolone as well as response and remission as evaluated by the 17-item Hamilton Rating Scale for Depression. In the zuranolone 50 mg cohort, nearly 75% of patients responded to the initial 2-week treatment course. Of those who responded to the initial course and continued in the study, approximately 80% of those patients received at most one additional zuranolone treatment during their time in the study. Enrollment of an anticipated 300 additional patients in the 50 mg cohort is ongoing. The companies plan to present additional data from the ongoing SHORELINE Study in future scientific forums.

ShowHide Related Items >><<
SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

11/18/21 Mizuho
Sage Therapeutics price target lowered to $44 from $52 at Mizuho
11/03/21 H.C. Wainwright
Sage Therapeutics price target lowered to $55 from $80 at H.C. Wainwright
11/02/21 RBC Capital
Sage Therapeutics price target lowered to $48 from $52 at RBC Capital
11/02/21 Piper Sandler
Sage's change to CORAL trial increases odds of approval, says Piper Sandler
BIIB Biogen
$235.67 /

-0.68 (-0.29%)

11/30/21 Wedbush
Wedbush keeps Neutral rating on Biogen after court denies appeal in patent case
11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

SAGE Sage Therapeutics
$38.85 /

+0.24 (+0.62%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

Tuesday
Periodicals
U.S. prepares stricter traveler testing amid omicron concerns, WP reports » 18:28
11/30/21
11/30
18:28
11/30/21
18:28
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$455.84 /

-8.8 (-1.89%)

, ALK

Alaska Air

$48.57 /

-0.87 (-1.76%)

, LUV

Southwest

$44.45 /

-0.095 (-0.21%)

, DAL

Delta Air Lines

$36.20 /

-0.03 (-0.08%)

, JBLU

JetBlue

$13.43 /

-0.09 (-0.67%)

, UAL

United Airlines

$42.25 /

-0.295 (-0.69%)

, SAVE

Spirit Airlines

$20.92 /

-0.38 (-1.78%)

, AAL

American Airlines

$17.69 /

-0.05 (-0.28%)

The White House is…

The White House is planning stricter testing requirements for all travelers entering the U.S., including returning U.S. citizens, to hinder the spread of the recently-discovered omicron variant of COVID-19, the Washington Post's Lena Sun and Tyler Pager report, citing three federal health officials. As part of a winter COVID strategy that President Joe Biden intends to unveil later this week, U.S. officials will require everyone entering the country to be tested one day prior to boarding flights, regardless of vaccination status or place of departure, the author says, noting that administration officials are also mulling a requirement that all travelers get retested within three to five days of arrival. Publicly traded companies in the space include Alaska Air (ALK), American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV), Spirit Airlines (SAVE) and United Airlines (UAL). Reference Link

ShowHide Related Items >><<
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

SPX S&P 500
/

+

11/26/21 Morgan Stanley
Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley
11/26/21 Credit Suisse
Concerns over new Covid variant 'understandable,' says Credit Suisse
11/22/21 BTIG
In picking Powell, Biden went with 'safest choice,' says BTIG
08/04/21 Citi
Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21 JPMorgan
Alaska Air price target raised to $97 from $94 at JPMorgan
07/20/21 Raymond James
Alaska Air price target lowered to $78 from $85 at Raymond James
07/12/21 Evercore ISI
Volaris price target raised to $30 from $25 at Evercore ISI
LUV Southwest
$44.45 /

-0.095 (-0.21%)

11/19/21
Fly Intel: Top five analyst upgrades
11/19/21 Wolfe Research
Southwest upgraded to Outperform from Peer Perform at Wolfe Research
11/16/21
Fly Intel: Top five analyst downgrades
11/16/21 Goldman Sachs
Southwest downgraded to Neutral from Buy at Goldman Sachs
DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

11/19/21 Wolfe Research
Delta Air Lines upgraded to Outperform from Peer Perform at Wolfe Research
10/29/21 BTIG
Call with Sharecare customers raises BTIG conviction in long-term outlook
10/14/21 Cowen
Delta Air Lines price target raised to $54 from $53 at Cowen
10/14/21 Morgan Stanley
Delta Air Lines price target lowered to $62 from $67 at Morgan Stanley
JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

11/17/21
Fly Intel: Top five analyst upgrades
11/17/21 Exane BNP Paribas
JetBlue upgraded to Neutral from Underperform at Exane BNP Paribas
10/06/21
Fly Intel: Top five analyst downgrades
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

10/21/21 Cowen
United Airlines price target raised to $78 from $72 at Cowen
08/11/21 Redburn
United Airlines initiated with a Sell at Redburn
07/22/21 MKM Partners
United Airlines price target lowered to $61 from $65 at MKM Partners
07/22/21 Susquehanna
United Airlines price target lowered to $51 from $56 at Susquehanna
SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

10/28/21 Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
AAL American Airlines
$17.69 /

-0.05 (-0.28%)

10/06/21 Goldman Sachs
American Airlines downgraded to Sell from Neutral at Goldman Sachs
08/11/21 Redburn
American Airlines initiated with a Buy at Redburn
07/27/21
Fly Intel: Top five analyst upgrades
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

  • 02
    Dec
UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPX S&P 500
/

+

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPX S&P 500
/

+

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

ALK Alaska Air
$48.57 /

-0.87 (-1.76%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

UAL United Airlines
$42.25 /

-0.295 (-0.69%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SAVE Spirit Airlines
$20.92 /

-0.38 (-1.78%)

LUV Southwest
$44.45 /

-0.095 (-0.21%)

JBLU JetBlue
$13.43 /

-0.09 (-0.67%)

DAL Delta Air Lines
$36.20 /

-0.03 (-0.08%)

AAL American Airlines
$17.69 /

-0.05 (-0.28%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

On The Fly
Wall Street in Fives - Must Read Lists for Tuesday » 16:22
11/30/21
11/30
16:22
11/30/21
16:22
REGN

Regeneron

$636.37 /

-17.98 (-2.75%)

, FB

Facebook; also tag MVRS

$324.30 /

-13.525 (-4.00%)

, MVRS

Meta

/

+

, SHOP

Shopify

$1,520.40 /

-48.74 (-3.11%)

, AMZN

Amazon.com

$3,507.58 /

-54.42 (-1.53%)

, $ECON

Economic Data

/

+

, SPY

SPDR S&P 500 ETF Trust

$455.84 /

-8.8 (-1.89%)

, SPX

S&P 500

/

+

, SQ

Square

$208.53 /

-4.46 (-2.09%)

, BYND

Beyond Meat

$70.33 /

-4.23 (-5.67%)

, RKLB

Rocket Lab

$15.90 /

+0.445 (+2.88%)

, DLTR

Dollar Tree

$133.57 /

-7.89 (-5.58%)

, VIR

Vir Biotechnology

$47.39 /

+6.87 (+16.95%)

, LULU

Lululemon

$454.65 /

-9.6 (-2.07%)

, MRNA

Moderna

$353.10 /

-15.085 (-4.10%)

, MRK

Merck

$74.87 /

-0.005 (-0.01%)

, BIIB

Biogen

$235.67 /

-0.68 (-0.29%)

, ZEN

Zendesk

$102.07 /

+6.955 (+7.31%)

, MNTV

Momentive

$20.46 /

-0.67 (-3.17%)

, MEIP

MEI Pharma

$3.44 /

+0.98 (+39.84%)

, IBRX

ImmunityBio

$7.77 /

+1.36 (+21.22%)

, RDHL

RedHill Biopharma

$2.91 /

+0.11 (+3.93%)

, OLMA

Olema Oncology

$8.77 /

-13.19 (-60.06%)

, VIAC

ViacomCBS

$30.93 /

-1.35 (-4.18%)

, VIACA

ViacomCBS

$33.38 /

-1.5 (-4.30%)

, CTRN

Citi Trends

$84.72 /

+6.7 (+8.59%)

, CHS

Chico's

$5.75 /

+0.21 (+3.79%)

, JKS

JinkoSolar

$52.32 /

-3.6 (-6.44%)

, BZUN

Baozun

$13.73 /

-1.1 (-7.42%)

, BNED

Barnes & Noble Education

$7.03 /

-1.865 (-20.97%)

Get caught up quickly on…

ShowHide Related Items >><<
ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

OLMA Olema Oncology
$8.77 /

-13.19 (-60.06%)

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

MEIP MEI Pharma
$3.44 /

+0.98 (+39.84%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

IBRX ImmunityBio
$7.77 /

+1.36 (+21.22%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

CTRN Citi Trends
$84.72 /

+6.7 (+8.59%)

CHS Chico's
$5.75 /

+0.21 (+3.79%)

BZUN Baozun
$13.73 /

-1.1 (-7.42%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

$ECON Economic Data
/

+

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
MVRS Meta
/

+

11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

11/24/21 Jefferies
Global-e deal for Flow Commerce strengthens D2C position, says Jefferies
11/15/21
Fly Intel: Top five analyst downgrades
11/15/21 Loop Capital
Shopify downgraded to Hold at Loop Capital on valuation
11/15/21 Loop Capital
Shopify downgraded to Hold from Buy at Loop Capital
AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

11/24/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
11/22/21 Guggenheim
Amazon.com assumed with a Buy at Guggenheim
11/19/21 RBC Capital
Williams-Sonoma price target raised to $219 from $199 at RBC Capital
11/18/21 Bernstein
Amazon card news in the U.K. 'clearly a show of strength,' says Bernstein
$ECON Economic Data
/

+

11/22/21 BTIG
In picking Powell, Biden went with 'safest choice,' says BTIG
08/04/21 Citi
Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

11/26/21 Morgan Stanley
Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley
11/26/21 Credit Suisse
Concerns over new Covid variant 'understandable,' says Credit Suisse
SPX S&P 500
/

+

SQ Square
$208.53 /

-4.46 (-2.09%)

11/30/21
Fly Intel: Top five analyst upgrades
11/30/21 BofA
Square upgraded to Neutral from Underperform at BofA
11/30/21 BofA
Square upgraded to Neutral from Underperform at BofA
11/17/21 UBS
Square initiated with a Buy at UBS
BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

11/30/21
Fly Intel: Top five analyst initiations
11/30/21 HSBC
HSBC starts Beyond Meat with sell on 'increasingly competitive' market
11/29/21 HSBC
Beyond Meat initiated with a Reduce at HSBC
11/15/21 Cowen
Beyond Meat price target lowered to $79 from $101 at Cowen
RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

11/30/21 BofA
Rocket Lab initiated with a Buy at BofA
11/30/21 BofA
Rocket Lab initiated with a Buy at BofA
10/04/21 BofA
Astra initiated with an Underperform at BofA
09/30/21 Stifel
Rocket Lab initiated with a Buy at Stifel
DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

11/30/21
Fly Intel: Top five analyst downgrades
11/29/21 Goldman Sachs
Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
11/29/21 Goldman Sachs
Dollar Tree downgraded to Neutral from Buy at Goldman Sachs
11/26/21 Morgan Stanley
Dollar Tree 'bull case path' to over $200 'getting clearer,' says Morgan Stanley
VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

11/30/21 H.C. Wainwright
Vir Biotechnology price target raised to $200 from $135 at H.C. Wainwright
11/17/21 Baird
Baird ups Vir Biotechnology target to $36 on new U.S. contract for Sotrovimab
10/25/21
Fly Intel: Top five analyst upgrades
10/25/21 JPMorgan
JPMorgan upgrades Vir to Neutral on estimate upside potential
LULU Lululemon
$454.65 /

-9.6 (-2.07%)

12/01/21 Argus
Lululemon price target raised to $530 from $500 at Argus
11/18/21 Cowen
Cowen lays out top retail picks into strongest holiday in 20 years
11/17/21 B. Riley
Lululemon price target raised to $548 from $466 at B. Riley
10/29/21 JPMorgan
Lululemon price target raised to $570 from $500 at JPMorgan
MRNA Moderna
$353.10 /

-15.085 (-4.10%)

11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
BIIB Biogen
$235.67 /

-0.68 (-0.29%)

11/30/21 Wedbush
Wedbush keeps Neutral rating on Biogen after court denies appeal in patent case
11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

11/30/21 Craig-Hallum
Zendesk price target lowered to $140 from $150 at Craig-Hallum
11/19/21
Fly Intel: Top five analyst downgrades
11/19/21 Stifel
Zendesk's upcoming deal proxy may help investors gain comfort, says Stifel
11/19/21 Cowen
Zendesk downgraded to Market Perform from Outperform at Cowen
MNTV Momentive
$20.46 /

-0.67 (-3.17%)

11/18/21 Jefferies
Zendesk price target lowered to $110 from $120 at Jefferies
11/16/21 Credit Suisse
Zendesk initiated with a Neutral at Credit Suisse
MEIP MEI Pharma
$3.44 /

+0.98 (+39.84%)

09/09/21 Truist
MEI Pharma price target lowered to $8 from $12 at Truist
09/07/21 Brookline
MEI Pharma price target raised to $20 from $11.50 at Brookline
04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
IBRX ImmunityBio
$7.77 /

+1.36 (+21.22%)

10/19/21 Piper Sandler
Piper says ImmunityBio could have 'blockbuster opportunity' with Anktiva
06/04/21 Piper Sandler
ImmunityBio shared 'positive data points' on N-803 at ASCO, says Piper Sandler
04/07/21 Piper Sandler
ImmunityBio price target raised to $25 from $18 at Piper Sandler
RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

12/01/21 BTIG
RedHill Biopharma price target lowered to $10 from $16 at BTIG
11/18/21
RedHill Biopharma files to sell common stock, no amount given
09/15/21 BTIG
RedHill Biopharma price target lowered to $16 from $24 at BTIG
09/15/21 H.C. Wainwright
RedHill Biopharma price target lowered to $21 from $23 at H.C. Wainwright
OLMA Olema Oncology
$8.77 /

-13.19 (-60.06%)

10/11/21
Olema Oncology participates in a conference call with JPMorgan
05/25/21 JPMorgan
Olema selloff brings 'compelling' entry point, says JPMorgan
12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

10/15/21 Deutsche Bank
ViacomCBS price target lowered to $44 from $45 at Deutsche Bank
08/18/21
Fly Intel: Top five analyst upgrades
08/18/21 Wells Fargo
ViacomCBS upgraded to Overweight from Equal Weight at Wells Fargo
08/06/21
Fly Intel: Top five analyst upgrades
VIACA ViacomCBS
$33.38 /

-1.5 (-4.30%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
CTRN Citi Trends
$84.72 /

+6.7 (+8.59%)

10/28/21
Citi Trends management to meet with Benchmark
09/21/21 Benchmark
Citi Trends initiated with a Buy at Benchmark
08/25/21 Craig-Hallum
Citi Trends price target raised to $165 from $150 at Craig-Hallum
05/26/21 Craig-Hallum
Citi Trends price target raised to $150 from $142 at Craig-Hallum
CHS Chico's
$5.75 /

+0.21 (+3.79%)

06/09/21 B. Riley
Chico's price target raised to $5.25 from $2.50 at B. Riley
03/03/21 B. Riley
Chico's price target raised to $2.50 from $2 at B. Riley Securities
01/15/21 B. Riley
Chico's price target raised to $2 from $1.50 at B. Riley Securities
JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

11/22/21 GLJ Research
U.S. to imminently appeal bi-facial solar panel decision, says GLJ Research
11/16/21 Roth Capital
Roth says court restoring solar 'bifi' exemption a 'major surprise'
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
11/10/21 Roth Capital
Anti-Circ thrown out, incremental negative for First Solar, says Roth Capital
BZUN Baozun
$13.73 /

-1.1 (-7.42%)

12/01/21 Citi
Baozun price target lowered to $19 from $22 at Citi
10/20/21 Citi
Baozun price target lowered to $22 from $34 at Citi
08/20/21 Daiwa
Baozun downgraded to Neutral from Buy at Daiwa
08/20/21 HSBC
Baozun price target lowered to $22 from $38 at HSBC
BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

MEIP MEI Pharma
$3.44 /

+0.98 (+39.84%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

IBRX ImmunityBio
$7.77 /

+1.36 (+21.22%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

CTRN Citi Trends
$84.72 /

+6.7 (+8.59%)

CHS Chico's
$5.75 /

+0.21 (+3.79%)

BZUN Baozun
$13.73 /

-1.1 (-7.42%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

  • 19
    Nov
  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
  • 02
    Mar
  • 23
    Feb
ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

MVRS Meta
/

+

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

$ECON Economic Data
/

+

ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

CHS Chico's
$5.75 /

+0.21 (+3.79%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

$ECON Economic Data
/

+

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

Recommendations
Wedbush keeps Neutral rating on Biogen after court denies appeal in patent case » 14:42
11/30/21
11/30
14:42
11/30/21
14:42
BIIB

Biogen

$232.82 /

-3.53 (-1.49%)

Wedbush analyst Laura…

Wedbush analyst Laura Chico notes that the U.S. Court of Appeals has ruled against Biogen in its Tecfidera patent appeal case. The decision arrives far later than expected with the case taking nearly a year following oral arguments to reach a ruling, Chico notes. The analyst believes this seems to remove any possibility of restarting Tecfidera exclusivity in the U.S. and anticipates continued erosion to continue. Against that backdrop, it would seem that Aduhelm is critical to the company's forward strategy, she contends. Chico awaits the CMS National Coverage Determination outcome, but even assuming broad access, she continues to see this as a challenging launch. The analyst keeps a Neutral rating on Biogen with a price target of $261.

ShowHide Related Items >><<
BIIB Biogen
$232.82 /

-3.53 (-1.49%)

BIIB Biogen
$232.82 /

-3.53 (-1.49%)

11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
11/17/21 Piper Sandler
'Hits just keep on coming' for Biogen, says Piper Sandler
BIIB Biogen
$232.82 /

-3.53 (-1.49%)

BIIB Biogen
$232.82 /

-3.53 (-1.49%)

BIIB Biogen
$232.82 /

-3.53 (-1.49%)

BIIB Biogen
$232.82 /

-3.53 (-1.49%)

Periodicals
Biogen denied appeal to revive patent on MS drug, Bloomberg reports » 14:41
11/30/21
11/30
14:41
11/30/21
14:41
BIIB

Biogen

$232.98 /

-3.37 (-1.43%)

Biogen has lost an appeal…

Biogen has lost an appeal bid to revive a key patent on the multiple sclerosis drug Tecfidera, reported Bloomberg's Susan Decker and Christopher Yasiejko. The U.S. Court of Appeals for the Federal Circuit ruled that a trial court was correct when it invalidated a patent on the medicine and the court also affirmed a decision by a review board within the U.S. Patent and Trademark office in a related ruling, Bloomberg said. Reference Link

ShowHide Related Items >><<
BIIB Biogen
$232.98 /

-3.37 (-1.43%)

BIIB Biogen
$232.98 /

-3.37 (-1.43%)

11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
11/17/21 Piper Sandler
'Hits just keep on coming' for Biogen, says Piper Sandler
BIIB Biogen
$232.98 /

-3.37 (-1.43%)

BIIB Biogen
$232.98 /

-3.37 (-1.43%)

BIIB Biogen
$232.98 /

-3.37 (-1.43%)

BIIB Biogen
$232.98 /

-3.37 (-1.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.